Printer Friendly

PFIZER SIGNS AGREEMENT TO SELL DEKNATEL

 PFIZER SIGNS AGREEMENT TO SELL DEKNATEL
 NEW YORK, Nov. 11 /PRNewswire -- Pfizer Inc (NYSE: PFE) said today


it has agreed to sell the Deknatel business of Pfizer Hospital Products Group to Deknatel management and outside investors. Headquartered in Fall River, Mass., Deknatel produces chest drainage systems, autotransfusion devices, sutures and other cardiovascular specialty products.
 The transaction, expected to be completed by year's end, would have no significant impact on Pfizer's financial results. Terms were not disclosed.
 Edward C. Bessey, Pfizer executive vice president, said, "We are pleased that current management has elected to buy the business. We feel that this will be in the best interests of the employees and bodes well for the future of Deknatel."
 Deknatel employs about 750 people worldwide with manufacturing locations in Fall River; Coventry, Conn.; Germany; and France.
 Bessey said the action is in line with a plan announced in July to divest Pfizer Laser Systems, Deknatel and certain of the Shiley product lines. Pfizer Laser Systems was sold earlier this year, and Pfizer is in discussions with a number of companies regarding the sale of certain Shiley product lines.
 -0- 11/11/91
 /CONTACT: A. A. Biesada, 212-573-2055, or Rick Honey, 212-573-2051, both of Pfizer/
 (PFE) CO: Pfizer Inc; Deknatel ST: Massachusetts, New York IN: MTC SU: TNM GK -- NY053 -- 3086 11/11/91 14:09 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 11, 1991
Words:224
Previous Article:KODAK REENTERS PREMIUM MARKET WITH POPULAR SINGLE USE CAMERAS
Next Article:SURVEY SAYS MANY CARDIOLOGISTS HAVE SWITCHED FROM TPA TO STREPTOKINASE IN THROMBOLYTIC THERAPY
Topics:


Related Articles
PFIZER ANNOUNCES CONTRACT TO SELL PRODUCT LINES OF SHILEY
PFIZER REACHES AGREEMENT FOR SETTLING SHILEY C/C HEART VALVE CLAIMS; AGREEMENT IS SUBJECT TO APPROVAL BY COURT
FALL RIVER MEDICAL SUPPLY COMPANY AND PFIZER, INC. PAY $675,000 IN SETTLEMENT OF GOVERNMENT'S CIVIL FRAUD CLAIMS
TAL,INC AWARDED DEKNATEL WORLDWIDE ADVERTISING
GENZYME TO ACQUIRE SURGICAL PRODUCTS COMPANY
SkyePharma Signs Contract for Pfizer Compound Using Its DepoFoam Injectable Technology.
Atrix Announces Major Agreement With Pfizer.
Maxygen Announces Follow-On Bioprocess Collaboration With Pfizer And Advancement of Product Candidate.
Genzyme files suit against Atrium for patent infringement.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters